Fmr LLC decreased its holdings in CRISPR Therapeutics AG ( NASDAQ:CRSP – Free Report ) by 2.1% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,139,056 shares of the company's stock after selling 45,328 shares during the quarter. Fmr LLC owned 2.71% of CRISPR Therapeutics worth $96,750,000 at the end of the most recent reporting period. Other institutional investors and hedge funds also recently made changes to their positions in the company.

https://www.dailypolitical.com/2023/09/04/fmr-llc-reduces-holdings-in-crispr-therapeutics-ag-nasdaqcrsp.html

#dailypolitical